Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Tibbetts Award To Cancer Researchers

September 25, 2006 | A version of this story appeared in Volume 84, Issue 39

James Bashkin and Chris Fisher, two scientists from both the University of Missouri, St. Louis, and NanoVir, a Kalamazoo, Mich.-based biotechnology company, have been honored with the Tibbetts Award in recognition of their work in identifying a potential treatment to fight the virus that causes cervical cancer.

Bashkin and Fisher have been seeking antiviral compounds that specifically target human papillomavirus (HPV) 16, the viral type most often associated with cervical cancer. Targeting the DNA of HPV rather than more traditional antiviral targets, the scientists identified a series of compounds that dramatically reduce the viral DNA load of cells harboring the virus.

The Tibbetts Award is given annually by the Small Business Innovation Research program of the Small Business Administration to small firms, projects, organizations, and individuals judged to exemplify the very best in SBIR achievement. Fisher and Bashkin will receive the award at a ceremony in Washington, D.C., on Sept. 26.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.